Does Phage Therapy Need a Pan-Phage?

Petros Bozidis,Eleftheria Markou,Athanasia Gouni,Konstantina Gartzonika

DOI: https://doi.org/10.3390/pathogens13060522

IF: 3.7

2024-06-21

Pathogens

Abstract:The emergence of multidrug-resistant bacteria is undoubtedly one of the most serious global health threats. One response to this threat that has been gaining momentum over the past decade is 'phage therapy'. According to this, lytic bacteriophages are used for the treatment of bacterial infections, either alone or in combination with antimicrobial agents. However, to ensure the efficacy and broad applicability of phage therapy, several challenges must be overcome. These challenges encompass the development of methods and strategies for the host range manipulation and bypass of the resistance mechanisms developed by pathogenic bacteria, as has been the case since the advent of antibiotics. As our knowledge and understanding of the interactions between phages and their hosts evolves, the key issue is to define the host range for each application. In this article, we discuss the factors that affect host range and how this determines the classification of phages into different categories of action. For each host range group, recent representative examples are provided, together with suggestions on how the different groups can be used to combat certain types of bacterial infections. The available methodologies for host range expansion, either through sequential adaptation to a new pathogen or through genetic engineering techniques, are also reviewed.

microbiology

What problem does this paper attempt to address?

The problem this paper attempts to address is: how to expand the host range of bacteriophages to improve the effectiveness and broad applicability of phage therapy.

Specifically, the paper discusses the following key issues:
1. **The threat of multidrug-resistant bacteria**: With the emergence of multidrug-resistant bacteria, the effectiveness of antibiotic treatments is severely challenged, and phage therapy as an alternative solution has garnered increasing attention.
2. **Challenges of phage therapy**: To ensure the effectiveness and broad applicability of phage therapy, multiple challenges need to be overcome, including the manipulation of host range and bypassing the resistance mechanisms of pathogens.
3. **Factors influencing host range**: The paper delves into the factors affecting the host range of bacteriophages, including cell surface receptors, cell wall components (such as peptidoglycan, lipopolysaccharides, S-layers, capsules, flagella, and pili), and the distribution and density of these structures in different bacteria.
4. **Classification of host range**: Based on the host range, bacteriophages can be categorized into different types, such as narrow host range phages and broad host range phages. The paper proposes a phage classification system based on host classification levels and provides representative examples from recent years.
5. **Methods to expand host range**: The paper also reviews existing methods, including expanding the host range of bacteriophages through continuous adaptation to new pathogens or genetic engineering techniques.

In summary, this paper aims to provide a theoretical foundation and technical support for developing more effective phage therapies by thoroughly exploring the interactions between bacteriophages and their hosts and the factors influencing these interactions.